Primary brachytherapy as a radical treatment for endometrial carcinoma

Journal of Contemporary Brachytherapy

Volumn 6, Issue 1, 2014, Pages 106-112

  Van Der Steen Banasik, Elzbieta ^a  

^a Arnhems Radiotherapeutisch Instituut   (Netherlands)

Author keywords

Brachytherapy; Endometrial cancer; HDR

Indexed keywords

ACUTE TOXICITY; BRACHYTHERAPY; BRACHYTHERAPY IMPLANT; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; ENDOMETRIUM CARCINOMA; ENTERITIS; EXTERNAL BEAM RADIOTHERAPY; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT COMFORT; PRACTICE GUIDELINE; RADIOTHERAPY PLANNING SYSTEM; RECURRENCE RISK; REVIEW; SALPINGOOOPHORECTOMY; SURVIVAL RATE; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; TUMOR VOLUME; UTERUS CAVITY;

EID: 84899545027     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2014.42028     Document Type: Review

References (32)

1. http://www.cancerresearchuk.org/cancer-help/type/womb; accessed March 2014.
2. Austin H, Austin JM Jr, Patridge EE et al. Endometrial cancer, obesity and body fat distribution. Cancer Res 1991; 51: 568-572.
3. http://www.cijfersoverkanker.nl/; accessed May 2014.
4. Benedetti PP, Basile S, Maneschi F et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100: 1707-1716.
5. Kitchener H, Swart AM, Qian Q et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 2009; 373: 125-136.
6. Creutzberg CL, van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicenter randomized trial. PORTEC Study Group. Postoperative Radiation Therapy in Endometrial Carcinoma. Lancet 2000; 355: 1404-1411. (Pubitemid 30215963)
7. Keys HM, Roberts JA, Brunetto VL et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92: 744-751. (Pubitemid 38251372)
8. Aalders J, Abeler V, Kolstad P et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980; 56: 419-427. (Pubitemid 10018299)
9. Blake P, Swart AM, Orton J et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomized trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009; 373: 137-146.
10. Nout RA, Smit VT, Putter H et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open label, non-inferiority, randomized trial. Lancet 2010; 375: 816-823.
11. Kellas-Ślȩczka S, Wojcieszek P, Białas B. Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer. J Contemp Brachytherapy 2012; 4: 247-252.
12. Donnelly E, Rakhra S, Helenowski I et al. Dosimetry and toxicity outcomes in postoperative high-dose-rate intracavitary brachytherapy for endometrial carcinoma J Contemp Brachytherapy 2012; 3: 135-140.
13. Hogberg T, Signorelli M, de Oliveira CF et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-results from two randomized studies. Eur J Cancer 2010; 46: 2422-2431.
14. Creasman WT, Odicino F, Maisonneuve P et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95 Suppl 1: S105-143.
15. http://www.oncoline.nl/endometriumcarcinoom; accessed March 2014.
16. Heyman J. The radiotherapeutic treatment of cancer corporis uteri. Br J Radiol 1947; 20: 85-91.
17. Jones DA, Stout R. Results of intracavitary radium treatment for adenocarcinoma of the body of the uterus. Clin Radiol 1986; 37: 169-171. (Pubitemid 16126997)
18. Grigsby PW, Kuske RR, Perez CA et al. Medically inoperable stage I adenocarcinoma of the endometrium treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 1987; 13: 483-488. (Pubitemid 17069641)
19. Taghian A, Pernot M, Hoffstetter S et al. Radiation therapy alone for medically inoperable patients with adenocarcinoma of the endometrium. Int J Radiat Oncol Biol Phys 1988; 15: 1135-1140. (Pubitemid 18265350)
20. Kupelian PA, Eifel PJ, Tornos C et al. Treatment of endometrial carcinoma with radiation therapy alone. Int J Radiat Oncol Biol Phys 1993; 27: 817-824. (Pubitemid 23340291)
21. Rose PG, Baker S, Kern M et al. Primary radiation therapy for endometrial carcinoma: a case controlled study. Int J Radiat Oncol Biol Phys 1993; 27: 585-590. (Pubitemid 23331125)
22. Rouanet P, Dubois J, Gely S et al. Exclusive radiation therapy in endometrial carcinoma. Int J Radiat Oncol Biol Phys 1993; 26: 223-228. (Pubitemid 23156968)
23. Chao CK, Grisby PW, Perez CA et al. Brachytherapy-related complications for medically inoperable stage I endometrial carcinoma. Int J Radiat Oncol Biol Phys 1995; 31: 37-42.
24. Coon D, Beriwal S, Heron D et al. High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year. Int J Radiat Oncol Biol Phys 2008; 71: 779-783.
25. Beriwal S, Kim H, Heron D et al. Comparison of 2D vs. 3D dosimetry for Rotte "Y" applicator high dose rate brachytherapy for medically inoperable endometrial cancer: 10-year. Technol Cancer Res Treat 2006; 5: 521-527. (Pubitemid 44606274)
26. Knocke TH, Kucer H, Weidinger B et al. Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: results of 12 years of experience with 280 patients. Int J Radiat Oncol Biol Phys 1997; 37: 359-365. (Pubitemid 27138720)
27. Weitmann HD, Potter R, Waldhause C et al. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2005; 62: 468-478. (Pubitemid 40704464)
28. Gerszten K, Faul C, Kelley J et al. Twice-daily high-rate brachytherapy for medically inoperable uterine cancer. Brachytherapy 2006; 5: 118-121.
29. Inciura A, Aktocius V, Juozaityte E et al. Long-term results of high-dose-rate brachytherapy and external-beam radiotherapy in the primary treatment of endometrial cancer. J Radiat Res 2010; 51: 675-681.
30. Niazi TM, Souhami L, Portelance L et al. Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma. Int J Radiat Oncol Biol Phys 2005; 63: 1108-1113. (Pubitemid 41505290)
31. Gerbaulet A, Pötter R, Mazeron JJ et al. The GEC ESTRO handbook of brachytherapy. ACCO, Leuven 2002.
32. Nag S, Erickson B, Parikh S et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 2000; 48: 779-790.